Last updated: 2026-09-06 05:21:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
MIRA Pharmaceuticals, Inc. (MIRA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.77, with a market capitalization of $35.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.60 to $2.45. This page covers its latest market performance, valuation, price trends and company information.
$35.70M | |
$0.74 | |
$7.98 | |
$0.51 | |
$0.74 | |
331.18K | |
-- | |
-- | |
$2.45 | |
$0.60 | |
-- | |
-- |
MIRA Pharmaceuticals, Inc. (MIRA) last closed at $0.74 as of 2026-09-04 22:47:00, unchanged from the previous close of $0.74.
During the latest regular trading session, MIRA traded between $0.51 and $7.98, with a volume of 331.18K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, MIRA Pharmaceuticals, Inc. (MIRA) moved from $0.75 to $0.77, representing a gain of 2.80% ($0.02).
The stock traded between $0.74 and $0.84 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 4.40 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 9.2%
MIRA is currently trading at $0.77, placing it 9.2% of the way from its 52-week low of $0.60 to its 52-week high of $2.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of MIRA Pharmaceuticals, Inc. (MIRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.